Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Immunol. 2016 Dec 3;185:3–9. doi: 10.1016/j.clim.2016.11.019

Table 3.

Time In Years Between First and Second Biopsies Multivarite Cox Proportional Hazard Ratio Analysis.Upper section evaluates time to ESRD, adjusting for multiple factors and lower evaluates time to death.

ESRD
Parameter Description Regression Coefficient p-Value Hazard Ratio
Age at First Renal Biopsy
 Age 18–50 ref. ref.
 Age<18 & Age>50 at First Renal Biopsy −0.162 0.773 0.850
Gender
 Female ref. ref.
 Male 0.267 0.517 1.307
Race/Ethnicity
 White ref. ref.
 Hispanic Ethnicity 0.997 0.121 2.711
 Black Race 0.832 0.190 2.298
First Biopsy Histopathologic Classification
 Mesangial (II) ref. ref.
 Membranous (V) 0.869 0.294 2.385
 Proliferative (III, IV, III+V, IV+V) 1.339 0.070 3.815
Induction Therapy
 Other (AZA, CYA) ref. ref.
 CYC 0.777 0.466 2.174
 MMF 0.634 0.555 1.886
 None or Unknown Induction Therapy −0.196 0.867 0.822
Time Between First and Second Biopsies
 >5 Years ref. ref.
 <1 Year 2.614 0.0001 13.65
 >1–5 Years 1.530 0.0028 4.619
DEATH
Parameter Description Regression Coefficient p-Value Hazard Ratio
Age at First Renal Biopsy
 Age 18–50 ref. ref.
 Age<18 & Age>50 at First Renal Biopsy 1.221 0.027 3.391
Gender
 Female ref. ref.
 Male 0.743 0.218 2.102
Race/Ethnicity
 White ref. ref.
 Hispanic Ethnicity 0.092 0.913 1.097
 Black Race 0.340 0.671 1.405
First Biopsy Histopathologic Classification
 Mesangial (II) ref. ref.
 Membranous (V) 0.343 0.699 1.409
 Proliferative (III, IV, III+V, IV+V) 0.042 0.958 1.043
Induction Therapy
 Other (AZA, CYA) ref. ref.
 CYC 1.053 0.383 2.866
 MMF 0.711 0.576 2.095
 None or Unknown Induction Therapy 1.847 0.143 6.340
Time Between First and Second Biopsies
 >5 Years ref. ref.
 <1 Year 2.825 0.002 16.860
 >1–5 Years 2.093 0.011 8.106